BACKGROUND: Heart failure results from abnormalities in multiple biological processes that contribute to cardiac dysfunction. We tested the hypothesis that inherited variation in genes of known importance to cardiovascular biology would thus contribute to heart failure risk. METHODS AND RESULTS: We used the ITMAT/Broad/CARe cardiovascular single-nucleotide polymorphism array to screen referral populations of patients with advanced heart failure for variants in approximately 2000 genes of predicted importance to cardiovascular biology. Our design was a 2-stage case-control study. In stage 1, genotypes in Caucasian patients with heart failure (n=1590; ejection fraction, 32+/-16%) were compared with those in unaffected controls (n=577; ejection fraction, 67+/-8%) who were recruited from the same referral centers. Associations were tested for independent replication in stage 2 (308 cases and 2314 controls). Two intronic single-nucleotide polymorphisms showed replicated associations with all-cause heart failure as follows: rs1739843 in HSPB7 (combined P=3.09x10(-6)) and rs6787362 in FRMD4B (P=6.09x10(-6)). For both single-nucleotide polymorphisms, the minor allele was protective. In subgroup analyses, rs1739843 associated with both ischemic and nonischemic heart failure, whereas rs6787362 associated principally with ischemic heart failure. Linkage disequilibrium surrounding rs1739843 suggested that the causal variant resides in a region containing HSPB7 and a neighboring gene, CLCNKA, whereas the causal variant near rs6787362 is probably within FRMD4B. Allele frequencies for these single-nucleotide polymorphisms were substantially different in African Americans (635 cases and 714 controls) and showed no association with heart failure in this population. CONCLUSIONS: Our findings identify regions containing HSPB7 and FRMD4B as novel susceptibility loci for advanced heart failure. More broadly, in an era of genome-wide association studies, we demonstrate how knowledge of candidate genes can be leveraged as a complementary strategy to discern the genetics of complex disorders.
BACKGROUND:Heart failure results from abnormalities in multiple biological processes that contribute to cardiac dysfunction. We tested the hypothesis that inherited variation in genes of known importance to cardiovascular biology would thus contribute to heart failure risk. METHODS AND RESULTS: We used the ITMAT/Broad/CARe cardiovascular single-nucleotide polymorphism array to screen referral populations of patients with advanced heart failure for variants in approximately 2000 genes of predicted importance to cardiovascular biology. Our design was a 2-stage case-control study. In stage 1, genotypes in Caucasian patients with heart failure (n=1590; ejection fraction, 32+/-16%) were compared with those in unaffected controls (n=577; ejection fraction, 67+/-8%) who were recruited from the same referral centers. Associations were tested for independent replication in stage 2 (308 cases and 2314 controls). Two intronic single-nucleotide polymorphisms showed replicated associations with all-cause heart failure as follows: rs1739843 in HSPB7 (combined P=3.09x10(-6)) and rs6787362 in FRMD4B (P=6.09x10(-6)). For both single-nucleotide polymorphisms, the minor allele was protective. In subgroup analyses, rs1739843 associated with both ischemic and nonischemic heart failure, whereas rs6787362 associated principally with ischemic heart failure. Linkage disequilibrium surrounding rs1739843 suggested that the causal variant resides in a region containing HSPB7 and a neighboring gene, CLCNKA, whereas the causal variant near rs6787362 is probably within FRMD4B. Allele frequencies for these single-nucleotide polymorphisms were substantially different in African Americans (635 cases and 714 controls) and showed no association with heart failure in this population. CONCLUSIONS: Our findings identify regions containing HSPB7 and FRMD4B as novel susceptibility loci for advanced heart failure. More broadly, in an era of genome-wide association studies, we demonstrate how knowledge of candidate genes can be leveraged as a complementary strategy to discern the genetics of complex disorders.
Authors: S Krief; J F Faivre; P Robert; B Le Douarin; N Brument-Larignon; I Lefrère; M M Bouzyk; K M Anderson; L D Greller; F L Tobin; M Souchet; A Bril Journal: J Biol Chem Date: 1999-12-17 Impact factor: 5.157
Authors: Saba Sile; Digna R Velez; Niloufar B Gillani; Charles A Alexander; Charles R Alexander; Alfred L George; Scott M Williams Journal: Hum Hered Date: 2007-07-25 Impact factor: 0.444
Authors: Sekar Kathiresan; Olle Melander; Dragi Anevski; Candace Guiducci; Noël P Burtt; Charlotta Roos; Joel N Hirschhorn; Göran Berglund; Bo Hedblad; Leif Groop; David M Altshuler; Christopher Newton-Cheh; Marju Orho-Melander Journal: N Engl J Med Date: 2008-03-20 Impact factor: 91.245
Authors: Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn Journal: Nat Med Date: 2008-04-20 Impact factor: 53.440
Authors: Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong Journal: Circulation Date: 2007-12-17 Impact factor: 29.690
Authors: Bruce M Psaty; Christopher J O'Donnell; Vilmundur Gudnason; Kathryn L Lunetta; Aaron R Folsom; Jerome I Rotter; André G Uitterlinden; Tamara B Harris; Jacqueline C M Witteman; Eric Boerwinkle Journal: Circ Cardiovasc Genet Date: 2009-02
Authors: Martin G Larson; Larry D Atwood; Emelia J Benjamin; L Adrienne Cupples; Ralph B D'Agostino; Caroline S Fox; Diddahally R Govindaraju; Chao-Yu Guo; Nancy L Heard-Costa; Shih-Jen Hwang; Joanne M Murabito; Christopher Newton-Cheh; Christopher J O'Donnell; Sudha Seshadri; Ramachandran S Vasan; Thomas J Wang; Philip A Wolf; Daniel Levy Journal: BMC Med Genet Date: 2007-09-19 Impact factor: 2.103
Authors: Hélène Choquet; Khanh K Thai; Chen Jiang; Dilrini K Ranatunga; Thomas J Hoffmann; Alan S Go; Alistair C Lindsay; Margaret G Ehm; Dawn M Waterworth; Neil Risch; Catherine Schaefer Journal: Circ Genom Precis Med Date: 2020-06-30
Authors: Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn Journal: Proc Natl Acad Sci U S A Date: 2011-01-19 Impact factor: 11.205
Authors: Djordje Djordjevic; Vinita Deshpande; Tomasz Szczesnik; Andrian Yang; David T Humphreys; Eleni Giannoulatou; Joshua W K Ho Journal: Biophys Rev Date: 2014-12-10
Authors: Klaus Stark; Ulrike B Esslinger; Wibke Reinhard; George Petrov; Thomas Winkler; Michel Komajda; Richard Isnard; Philippe Charron; Eric Villard; François Cambien; Laurence Tiret; Marie-Claude Aumont; Olivier Dubourg; Jean-Noël Trochu; Laurent Fauchier; Pascal Degroote; Anette Richter; Bernhard Maisch; Thomas Wichter; Christa Zollbrecht; Martina Grassl; Heribert Schunkert; Patrick Linsel-Nitschke; Jeanette Erdmann; Jens Baumert; Thomas Illig; Norman Klopp; H-Erich Wichmann; Christa Meisinger; Wolfgang Koenig; Peter Lichtner; Thomas Meitinger; Arne Schillert; Inke R König; Roland Hetzer; Iris M Heid; Vera Regitz-Zagrosek; Christian Hengstenberg Journal: PLoS Genet Date: 2010-10-21 Impact factor: 5.917
Authors: Vivian T Laquer; Peter A Hevezi; Huguette Albrecht; Tina S Chen; Albert Zlotnik; Kristen M Kelly Journal: Lasers Surg Med Date: 2013-02 Impact factor: 4.025
Authors: Nuala J Meyer; Rui Feng; Mingyao Li; Yang Zhao; Chau-Chyun Sheu; Paula Tejera; Robert Gallop; Scarlett Bellamy; Melanie Rushefski; Paul N Lanken; Richard Aplenc; Grant E O'Keefe; Mark M Wurfel; David C Christiani; Jason D Christie Journal: Am J Respir Crit Care Med Date: 2013-05-01 Impact factor: 21.405